REVANCE THERAPEUTICS, INC.

Revance Therapeutics, Inc reported a data breach to the Montana Attorney General. The breach was reported on 2023-07-10. The breach occurred from 3/15/2023 to 4/10/2023. 2 Montana residents were affected.

On April 9, 2023, Revance Therapeutics, Inc. discovered that an unauthorized third party had accessed its systems between March 15, 2023, and April 10, 2023, by compromising an employee's credentials. The investigation, completed on June 15, 2023, confirmed that personal information, including financial account details, was exfiltrated. The company has since enhanced its security controls, notified law enforcement, and offered 24 months of identity monitoring services to affected individuals.

Revance Therapeutics, Inc. reported a data breach affecting 2,803 individuals after an unauthorized third party accessed company systems using compromised employee credentials between March 15, 2023, and April 10, 2023. The breach was discovered on April 9, 2023. The compromised information included names and financial account numbers with access codes. In response, Revance engaged a cybersecurity firm, notified law enforcement, and offered 24 months of identity monitoring services to affected individuals. The company has since enhanced its identity access and authentication controls.

Revance Therapeutics, Inc. disclosed that an unauthorized third party accessed and exfiltrated personal information from its systems between March 15, 2023, and April 10, 2023. The company discovered the incident on April 9, 2023. Affected data includes names and other personal information. Revance terminated the attacker's access, engaged cybersecurity specialists, notified law enforcement, and offered two years of identity monitoring through Kroll.